Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shingrix
Fierce Pharma
GSK's Emma Walmsley to step down as CEO in shock move
GSK’s chief Emma Walmsley will move aside for her chief commercial officer Luke Miels next year.
Ben Adams
Sep 29, 2025 3:39am
Dynavax's vaccine holds its own against Shingrix in early test
Aug 21, 2025 8:00am
GSK seeks link between shingles vax and lower dementia risk
Mar 25, 2025 5:00am
Curevo clinches $110M, nabs Moncef Slaoui to lead board
Mar 17, 2025 10:44am
Curevo’s shingles vaccine equals Shingrix in ph. 2 head-to-head
Jan 8, 2024 9:44am
Takeda spinout HilleVax hits Wall St., a test of choppy waters
Apr 7, 2022 10:48am
